Muna Therapeutics Announces CEO Transition as Clinical Pipeline Advances

After leading Muna's evolution into a clinical-stage company, Rita Balice-Gordon, Ph.D., will step down and join the Board of Directors; former iTeos President & CEO Michel Detheux, Ph.D., appointed Chief Executive Officer Company remains focused on developing new therapies to treat...